Phibro Animal Health (NASDAQ:PAHC) CEO Sells $391,380.47 in Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 8,801 shares of the company’s stock in a transaction dated Thursday, November 13th. The shares were sold at an average price of $44.47, for a total value of $391,380.47. Following the completion of the transaction, the chief executive officer owned 5,240 shares in the company, valued at $233,022.80. This represents a 62.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Jack Bendheim also recently made the following trade(s):

• On Wednesday, November 12th, Jack Bendheim sold 21,536 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.23, for a total transaction of $974,073.28.
• On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.29, for a total transaction of $1,734,742.87.
• On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $42.86, for a total transaction of $150,867.20.
• On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.10, for a total transaction of $151,712.00.
• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.07, for a total transaction of $144,566.40.
• On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.56, for a total transaction of $146,291.20.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.18, for a total value of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.27, for a total value of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.38, for a total value of $649,108.50.
• On Friday, October 17th, Jack Bendheim sold 700 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.03, for a total value of $28,021.00.

Phibro Animal Health Stock Up 0.9%

PAHC opened at $45.10 on Friday. The company has a market capitalization of $1.83 billion, a PE ratio of 38.22, a price-to-earnings-growth ratio of 1.24 and a beta of 0.81. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.76 and a quick ratio of 1.25. Phibro Animal Health Corporation has a fifty-two week low of $16.16 and a fifty-two week high of $46.42. The business has a 50-day moving average of $40.43 and a 200-day moving average of $31.89.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 EPS for the quarter, topping analysts’ consensus estimates of $0.58 by $0.15. The firm had revenue of $363.89 million for the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. Equities research analysts forecast that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 17th. Stockholders of record on Wednesday, November 26th will be paid a dividend of $0.12 per share. The ex-dividend date is Wednesday, November 26th. This represents a $0.48 annualized dividend and a dividend yield of 1.1%. Phibro Animal Health’s dividend payout ratio is 28.92%.

Institutional Investors Weigh In On Phibro Animal Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Creative Planning acquired a new position in shares of Phibro Animal Health during the 3rd quarter worth about $217,000. Lazard Asset Management LLC increased its position in Phibro Animal Health by 8.6% in the 3rd quarter. Lazard Asset Management LLC now owns 100,369 shares of the company’s stock worth $4,061,000 after buying an additional 7,928 shares during the period. Zacks Investment Management lifted its holdings in shares of Phibro Animal Health by 13.1% during the third quarter. Zacks Investment Management now owns 80,749 shares of the company’s stock worth $3,267,000 after buying an additional 9,361 shares during the last quarter. Credit Agricole S A bought a new stake in shares of Phibro Animal Health in the third quarter valued at approximately $1,293,000. Finally, Raymond James Financial Inc. grew its stake in shares of Phibro Animal Health by 122.6% in the third quarter. Raymond James Financial Inc. now owns 111,623 shares of the company’s stock worth $4,516,000 after acquiring an additional 61,473 shares during the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently issued reports on PAHC. JPMorgan Chase & Co. lifted their price objective on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a research report on Tuesday. Zacks Research lowered Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a report on Monday, November 10th. Bank of America raised their price objective on Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a research note on Friday, August 29th. Finally, Morgan Stanley set a $34.00 target price on Phibro Animal Health in a research report on Thursday, August 28th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $31.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.